Previous 10 | Next 10 |
Are These Under $2 Penny Stocks Worth Buying on Robinhood? Finding penny stocks to buy on Robinhood is one of the most popular choices for small-caps investors right now. And with hundreds to choose from, it can seem like a daunting task to find just a handful of penny stocks for yo...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re halfway through the week and what better way to begin the day than with a look at the biggest pre-market stock movers for Wednesday! Source: Shutterstock But before that, consider ...
Insiders Are Buying Up Shares Of These Penny Stocks This Month Insider trading can be an important signal to the stock market. Today, with hundreds of penny stocks to choose from, sentiment has become a factor to account for. Sure, you’ve got your social sentiment from platforms ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re back at it once again with another update on the biggest pre-market stock movers for Thursday. Source: oneinchpunch/Shutterstock.com But before that, check out what happened on th...
Salarius Pharmaceuticals, Inc. (SLRX) Q2 2021 Earnings Conference Call August 05, 2021 10:00 AM ET Company Participants Jason Rando - Investor Relations, Executive Vice President, Chief Operating Officer, Tiberend Strategic Advisors David Arthur - Director & Chief Executive Officer Mark R...
Clinical Trial in Hematologic Cancers Initiated and Initial Patients Enrolled in Expanded Sarcoma Clinical Trial; Multiple Potential Data Readouts Expected in 2021 and 2022 Preliminary Efficacy Findings from Sarcoma and Advanced Solid Tumor Trials Presented at American Society of ...
HOUSTON, July 29, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other solid and hematologic cancers, today announced that the Company wi...
HOUSTON, July 14, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that Aundrietta Duncan, Ph.D....
Salarius Pharmaceuticals (SLRX) announces that Fox Chase Cancer Center has been added as an active trial site for the dose-expansion stage of the ongoing trial evaluating seclidemstat in patients with relapsed or refractory Ewing sarcoma and advanced FET-rearranged sarcomas.The addi...
HOUSTON, July 13, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that Fox Chase Cancer Center in P...
News, Short Squeeze, Breakout and More Instantly...
Salarius Pharmaceuticals Inc. Company Name:
SLRX Stock Symbol:
NASDAQ Market:
Salarius Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 1.7% to $112.28 on volume of 455,296,152 shares Ford Motor Company (F) fell 18.4% to $11.16 on volume of 256,384,806 shares PROSHARES TRUST (SQQQ) rose 3.4% to $9.37 on volume of 246,885,889 shares Sel...
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) is one of today's top gainers. The company's shares have moved 57.21% on the day to $3.37. Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Secli...
A look at the top 10 most actives in the United States Predictive Oncology Inc. (POAI) rose 115.9% to $2.3099 on volume of 63,737,015 shares Selina Hospitality PLC (SLNA) fell 11.2% to $0.0406 on volume of 59,708,638 shares NVIDIA Corporation (NVDA) fell 1.4% to $112.695 on volume of 52,2...